About U.O. Ematologia Clinica - Azienda USL di Pescara
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at U.O. Ematologia Clinica - Azienda USL di Pescara
During the past decade, U.O. Ematologia Clinica - Azienda USL di Pescara conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 9 clinical trials were completed, i.e. on
average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 4 clinical trials were completed. i.e. 44.4%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "U.O. Ematologia Clinica - Azienda USL di Pescara" #1 sponsor was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 37 trials, followed by "Fondazione Italiana Linfomi ONLUS" with 5 trials
sponsored, "Hoffmann-La Roche" with 5 trials sponsored, "Incyte Corporation" with 1 trials sponsored and "University Hospital Muenster"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "U.O. Ematologia Clinica - Azienda USL di Pescara"
#1 collaborator was "Deutsche Krebshilfe e.V., Bonn (Germany)" with 2 trials as a collaborator, "Fondazione Adecco per le Pari Opportunità" with 1 trials as a collaborator and "Study Alliance Leukemia (SAL) Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at U.O. Ematologia Clinica - Azienda USL di Pescara
According to Clinical.Site data, the most researched conditions in "U.O. Ematologia Clinica - Azienda USL di Pescara" are
"Chronic Lymphocytic Leukemia" (5 trials), "Leukemia" (5 trials), "Chronic Myeloid Leukemia" (4 trials), "Non-Hodgkin's Lymphoma" (4 trials) and "Acute Lymphoblastic Leukemia" (3 trials). Many other conditions were trialed in "U.O. Ematologia Clinica - Azienda USL di Pescara" in a lesser frequency.
Clinical Trials Intervention Types at U.O. Ematologia Clinica - Azienda USL di Pescara
Most popular intervention types in "U.O. Ematologia Clinica - Azienda USL di Pescara" are "Drug" (41 trials), "Other" (7 trials), "Procedure" (4 trials), "Behavioral" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.
The name of intervention was led by "Imatinib" (3 trials), "dexamethasone" (3 trials), "mercaptopurine" (3 trials), "methotrexate" (3 trials) and "prednisone" (3 trials). Other intervention names were less common.
Clinical Trials Genders at U.O. Ematologia Clinica - Azienda USL di Pescara
The vast majority of trials in "U.O. Ematologia Clinica - Azienda USL di Pescara" are
50 trials for "All" genders.
Clinical Trials Status at U.O. Ematologia Clinica - Azienda USL di Pescara
Currently, there are NaN active trials in "U.O. Ematologia Clinica - Azienda USL di Pescara".
undefined are not yet recruiting,
9 are recruiting,
8 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 28 completed trials in U.O. Ematologia Clinica - Azienda USL di Pescara,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in U.O. Ematologia Clinica - Azienda USL di Pescara, 2 "Phase 1"
clinical trials were conducted, 23 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 1 trials that are defined as “Not Applicable".